Latest Investment News

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Centaurus Metals has achieved a major milestone with the granting of the Jaguar Nickel Sulphide Project mining lease and reported promising new copper-gold discoveries at its Boi Novo project, underpinning its growth ambitions in Brazil.

Black Dragon Gold’s latest quarterly report highlights strong local backing for its Salave gold project in Spain, alongside a key director resignation and a stable cash position of CAD$882,000.

Energy World Corporation focused on advancing its capital raising and asset sales in Q3 2025, ending the quarter with $15 million in cash but no revenue generation.

Ryzon Materials has made significant progress on the Nachu Graphite Project with detailed engineering funded through equity, while securing debt conversion and additional financial support despite ongoing ASX suspension.

Assetora Limited disclosed a $341,000 net operating cash outflow for the September 2025 quarter, supported by $1.6 million in total available funding including cash reserves and financing facilities.

Orbital Corporation Ltd reports a robust Q1 2025 with increased revenues, successful prototype completion of a new 350cc heavy fuel engine, and strategic partnerships positioning it for growth in the evolving UAV market.

Savannah Goldfields reported a challenging quarter with significant cash outflows but bolstered its position through a $15 million equity raise, setting the stage for a planned restart of gold production.

Cycliq Group has completed a major e-commerce platform upgrade while preparing inventory for the critical Cyber November sales, reporting a 35% drop in quarterly customer receipts as it invests in future growth.

Anteris Technologies Global Corp. has had its trading suspension lifted following a key announcement about its capital raising plans, signaling renewed market activity.

Anteris Technologies Global Corp. has raised A$38.5 million in a private placement to accelerate the global commercialization and pivotal clinical trial of its innovative DurAVR® transcatheter aortic valve replacement device.

SOCO Corporation has returned to profitability in FY25, driven by strategic contract wins and client diversification. The company is now focusing on expanding recurring revenues and leveraging AI and cybersecurity capabilities for future growth.